Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Janssen

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Cancer Medicine|October 20, 2021
First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Results of the NEPTUN studyTobias Dechow, Jorge Riera-Knorrenschild, Björn Hackanson, et al.
BMC Cancer|February 25, 2026
ERBITAG: Non-interventional study on the efficacy of cetuximab in first-line therapy in patients with RAS wild-type metastatic colorectal cancerStephan W Sahm, Ulf Peter Neumann, Mark-Oliver Zahn, et al.
BMC Cancer|May 1, 2015
Everolimus in metastatic renal cell carcinoma after failure of initial anti-VEGF therapy: final results of a noninterventional studyLothar Bergmann, Ulrich Kube, Christian Doehn, et al.
International Journal of Cancer|February 9, 2023
First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Final results of the NEPTUN studyTobias Dechow, Jorge Riera-Knorrenschild, Björn Hackanson, et al.
Onkologie|March 15, 2013
Everolimus in metastatic renal cell carcinoma after failure of initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy: results of an interim analysis of a non-interventional studyLothar Bergmann, Peter J Goebell, Ulrich Kube, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 4, 2011
Efficacy of an artificial neural network-based approach to endoscopic ultrasound elastography in diagnosis of focal pancreatic massesAdrian Săftoiu, Peter Vilmann, Florin Gorunescu, et al.
RSC Advances|May 11, 2022
Design of triphasic poly(lactic-<i>co</i>-glycolic acid) nanoparticles containing a perfluorocarbon phase for biomedical applicationsEdyta Swider, Alexander H J Staal, N Koen van Riessen, et al.
International Immunopharmacology|November 2, 2017
Corrigendum to "Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia" [Int. Immunopharmacol. 44 (2017) 38-42]Giuseppe Spadaro, Alessandra Vultaggio, Alberto Bosi, et al.
International Immunopharmacology|January 11, 2017
Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopeniaGiuseppe Spadaro, Alessandra Vultaggio, A Alberto Bosi, et al.
Leukemia & Lymphoma|December 10, 2024
Treatment adherence and effectiveness in patients treated with carfilzomib-based therapy combinations for relapsed/refractory multiple myeloma in Germany: interim results from the non-interventional CARO studyWolfgang Knauf, Jens Uhlig, Eyck von der Heyde, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Cancer Medicine|October 20, 2021
First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Results of the NEPTUN studyTobias Dechow, Jorge Riera-Knorrenschild, Björn Hackanson, et al.
BMC Cancer|February 25, 2026
ERBITAG: Non-interventional study on the efficacy of cetuximab in first-line therapy in patients with RAS wild-type metastatic colorectal cancerStephan W Sahm, Ulf Peter Neumann, Mark-Oliver Zahn, et al.
BMC Cancer|May 1, 2015
Everolimus in metastatic renal cell carcinoma after failure of initial anti-VEGF therapy: final results of a noninterventional studyLothar Bergmann, Ulrich Kube, Christian Doehn, et al.
International Journal of Cancer|February 9, 2023
First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Final results of the NEPTUN studyTobias Dechow, Jorge Riera-Knorrenschild, Björn Hackanson, et al.
Onkologie|March 15, 2013
Everolimus in metastatic renal cell carcinoma after failure of initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy: results of an interim analysis of a non-interventional studyLothar Bergmann, Peter J Goebell, Ulrich Kube, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 4, 2011
Efficacy of an artificial neural network-based approach to endoscopic ultrasound elastography in diagnosis of focal pancreatic massesAdrian Săftoiu, Peter Vilmann, Florin Gorunescu, et al.
RSC Advances|May 11, 2022
Design of triphasic poly(lactic-<i>co</i>-glycolic acid) nanoparticles containing a perfluorocarbon phase for biomedical applicationsEdyta Swider, Alexander H J Staal, N Koen van Riessen, et al.
International Immunopharmacology|November 2, 2017
Corrigendum to "Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia" [Int. Immunopharmacol. 44 (2017) 38-42]Giuseppe Spadaro, Alessandra Vultaggio, Alberto Bosi, et al.
International Immunopharmacology|January 11, 2017
Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopeniaGiuseppe Spadaro, Alessandra Vultaggio, A Alberto Bosi, et al.
Leukemia & Lymphoma|December 10, 2024
Treatment adherence and effectiveness in patients treated with carfilzomib-based therapy combinations for relapsed/refractory multiple myeloma in Germany: interim results from the non-interventional CARO studyWolfgang Knauf, Jens Uhlig, Eyck von der Heyde, et al.
Pageof 4